{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:36:52Z","timestamp":1793911012761,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011901","name":"Rajiv Gandhi Science and Technology Commission","doi-asserted-by":"publisher","award":["RGSTC\/file-2021\/DPP-254\/CR-76\/268"],"award-info":[{"award-number":["RGSTC\/file-2021\/DPP-254\/CR-76\/268"]}],"id":[{"id":"10.13039\/501100011901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rmed.2026.109206","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:04:34Z","timestamp":1791561874000},"page":"109206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serological profile in differentiating Interstitial Lung Disease (ILD) subtypes: A report from Western India"],"prefix":"10.1016","volume":"263","author":[{"given":"Tanya","family":"Athavale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Athavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaya","family":"Tipnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Neman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-2217","authenticated-orcid":false,"given":"Amrutha","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridi","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-3123","authenticated-orcid":false,"given":"Durga","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanusha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Nadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Rajadhyaksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.rmed.2026.109206_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial lung disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2026.109206_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.751181","article-title":"Variability in global prevalence of interstitial lung disease","volume":"8","author":"Kaul","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib3","article-title":"Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review","volume":"10","author":"Shah Gupta","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.rmed.2026.109206_bib4","article-title":"Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years","volume":"13","author":"Zhou","year":"2025","journal-title":"Front. Public Health"},{"issue":"7","key":"10.1016\/j.rmed.2026.109206_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271665","article-title":"Incidence, prevalence, and national burden of interstitial lung diseases in India: estimates from two studies of 3089 subjects","volume":"17","author":"Dhooria","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib6","article-title":"Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS\/ATS statement","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109206_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.680997","article-title":"Biomarkers in progressive fibrosing interstitial lung disease: optimizing diagnosis, prognosis, and treatment response","volume":"8","author":"Bowman","year":"2021","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.109206_bib9","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109206_bib10","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109206_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/lungindia.lungindia_275_20","article-title":"Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP)","volume":"37","author":"Singh","year":"2020","journal-title":"Lung India"},{"key":"10.1016\/j.rmed.2026.109206_bib12","series-title":"Presented at: European Respiratory Society International Congress","first-page":"PA6114","article-title":"Radiographic patterns and signs of fibrosing interstitial lung diseases: overlooked clues for autoimmune pulmonary manifestations","author":"Hernandez Gonzalez","year":"2025"},{"key":"10.1016\/j.rmed.2026.109206_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.35120\/medisij0403017n","article-title":"HRCT patterns in fibrotic interstitial lung diseases: comparative analysis of idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, and connective tissue disease-related ILD","volume":"4","author":"Nikolova","year":"2025","journal-title":"Medisij"},{"key":"10.1016\/j.rmed.2026.109206_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120473","article-title":"Interstitial lung disease biomarkers: a systematic review and meta-analysis","volume":"577","author":"Tzang","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2213-2600(21)00503-8","article-title":"Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis","volume":"10","author":"Bowman","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109206_bib16","article-title":"Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease","volume":"19","author":"d'Alessandro","year":"2024","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.rmed.2026.109206_bib17","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3390\/jcm10143167","article-title":"Serum biomarkers in differential diagnosis of idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease","volume":"10","author":"Cabrera Cesar","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-025-01128-2","article-title":"Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis","volume":"31","author":"Pulito-Cueto","year":"2025","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.rmed.2026.109206_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1183\/23120541.00553-2024","article-title":"Serum metalloproteinase-7 as a biomarker of progressive pulmonary fibrosis","volume":"10","author":"Ara\u00fajo","year":"2024","journal-title":"ERJ Open Res"},{"issue":"8","key":"10.1016\/j.rmed.2026.109206_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.109206_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.rmed.2013.06.004","article-title":"CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases","volume":"107","author":"Cai","year":"2013","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib23","doi-asserted-by":"crossref","DOI":"10.35534\/fibrosis.2023.10004","article-title":"Comprehensive landscape of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"1","author":"Li","year":"2023","journal-title":"Fibrosis"},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70162","article-title":"Fibroblast-driven MMP-9\/TIMP-1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease","volume":"56","author":"Bertolotto","year":"2026","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.rmed.2026.109206_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109206_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.17305\/bb.2024.10368","article-title":"Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: a meta-analysis","volume":"24","author":"Hong","year":"2024","journal-title":"Biomol Biomed"},{"issue":"3","key":"10.1016\/j.rmed.2026.109206_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ijms26031091","article-title":"Serum KL-6 and SP-D: markers of lung function in autoimmune-related interstitial lung diseases","volume":"26","author":"Mi\u0105dlikowska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib28","article-title":"Serum lactate dehydrogenase as a prognostic marker for 90-day mortality in connective tissue disease patients receiving glucocorticoids and hospitalized with pneumonia: a cohort study","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2026.109206_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s40064-015-1455-z","article-title":"Soluble intercellular adhesion molecule-1 for stable and acute phases of idiopathic pulmonary fibrosis","volume":"4","author":"Okuda","year":"2015","journal-title":"SpringerPlus"},{"issue":"15","key":"10.1016\/j.rmed.2026.109206_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512518","article-title":"E-Selectin, ICAM-1, and ET-1 biomarkers address the concern of the challenging diagnosis of interstitial lung disease in patients with autoimmune diseases","volume":"24","author":"Pulito-Cueto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2026.109206_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1174443","article-title":"Novel diagnostic techniques in interstitial lung disease","volume":"10","author":"Glenn","year":"2023","journal-title":"Front. Med."},{"issue":"24","key":"10.1016\/j.rmed.2026.109206_bib32","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/jcm13247657","article-title":"Put Down the ACE: low clinical utility for angiotensin-converting enzyme levels in sarcoidosis: a single-center retrospective cohort Study","volume":"13","author":"Druyan","year":"2024","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109206_bib33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.107.3.706","article-title":"Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD","volume":"107","author":"Brice","year":"1995","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rmed.2026.109206_bib34","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","article-title":"Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.rmed.2026.109206_bib35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.rmed.2026.109206_bib36","article-title":"Anti-melanoma differentiation-associated protein 5 (MDA5)-positive dermatomyositis with rapidly progressive Interstitial Lung Disease (ILD): a rare and lethal entity to recognize early","volume":"16","author":"Bernardino","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.rmed.2026.109206_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.31138\/mjr.180324.dtc","article-title":"Prevalence of anti-synthetase syndrome in patients of interstitial lung disease with connective tissue diseases and autoimmune features: a cross-sectional study","volume":"36","author":"Mb","year":"2025","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"10.1016\/j.rmed.2026.109206_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00408-009-9223-x","article-title":"Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis","volume":"188","author":"Ando","year":"2010","journal-title":"Lung"},{"issue":"16","key":"10.1016\/j.rmed.2026.109206_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92192","article-title":"Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis","volume":"2","author":"Murray","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.rmed.2026.109206_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241272928","article-title":"Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis","volume":"18","author":"Yoon","year":"2024","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.03.00091802","article-title":"Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?","volume":"22","author":"Prasse","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109206_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","article-title":"A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis","volume":"350","author":"Raghu","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109206_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.rmed.2026.109206_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00296-022-05250-w","article-title":"Serum levels of interleukin 17 and 22 in patients with systemic sclerosis: a single-center cross-sectional study","volume":"43","author":"Kardum","year":"2023","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.rmed.2026.109206_bib45","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/biomedicines13061463","article-title":"Predictive biomarkers and novel treatments for the progressive fibrosing phenotype in interstitial lung disease associated with connective tissue disease","volume":"13","author":"Chung","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.rmed.2026.109206_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1165\/rcmb.2013-0386OC","article-title":"Tumor necrosis factor-\u03b1 accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages","volume":"50","author":"Redente","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:15:08Z","timestamp":1793909708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126005755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S0954611126005755"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109206","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological profile in differentiating Interstitial Lung Disease (ILD) subtypes: A report from Western India","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109206"}}